Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer

References

• Ahmadzai H, Huang S, Hettiarachchi R, et al. (2013). Exhaled breath condensate: a comprehensive update. Clin Chem Lab Med 51:1343–61
   PubMed Web of Science ®Google Scholar
• Belinsky SA. (2004). Gene promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 4:707–17
   PubMed Web of Science ®Google Scholar
• Boeri M, Verri C, Conte D, et al. (2011). MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Nat Acad Sci USA 108:3713–18
   PubMed Web of Science ®Google Scholar
• Boeri M, Pastorino U, Sozzi G. (2012). Role of MicroRNAs in lung cancer: microRNA signatures in cancer prognosis. Cancer J 18:268–74
   PubMed Web of Science ®Google Scholar
• Cao JQ, Rodrigues GB, Louie AV, Zaric GS. (2012). Systematic review of the cost-effectiveness of positron-emission tomography in staging of non-small-cell lung cancer and management of solitary pulmonary nodules. Clin Lung Cancer 13:161–70
   PubMed Web of Science ®Google Scholar
• Chan HP, Lewis C, Thomas PS. (2009). Exhaled breath analysis: novel approach for early detection of lung cancer. Lung Cancer 63:164–8
   PubMed Web of Science ®Google Scholar
• Chan, JA, Krichevsky AM, Kosik KS. (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029–33
   PubMed Web of Science ®Google Scholar
• Cherni I, Weiss GJ. (2011). miRNAs in lung cancer: large roles for small players. Future Oncol 7:1045–55
   PubMed Web of Science ®Google Scholar
• De Groot P, Munden RF. (2012). Lung cancer epidemiology, risk factors, and prevention. Radiol Clin North Am 50:863–7
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. (2006). Oncomirs – microRNAs with a role in cancer. Nat Rev Cancer 6:259–69
   PubMed Web of Science ®Google Scholar
• Goldoni M, Caglieri A, Andreoli R, et al. (2005). Influence of condensation temperature on selected exhaled breath parameters. BMC Pulm Med 5:10
   PubMedGoogle Scholar
• Greenlee RT, Hill-Harmon MB, Murray T, Thun M. (2001). Cancer statistics 2001. CA Cancer J Clin 51:15–36
   PubMed Web of Science ®Google Scholar
• Hassanein M, Callison JC, Callaway-Lane C, et al. (2012). The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila) 5:992–1006
   PubMed Web of Science ®Google Scholar
• Hatley ME, Patrick DM, Garcia MR, et al. (2010). Modulation of K-Ras-dependent lung tumorigenesis by micro-RNA 21. Cancer Cell 18:282–93
   PubMed Web of Science ®Google Scholar
• Heegaard NH, Schetter AJ, Welsh JA, et al. (2012). Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer 130:1378–86
   PubMed Web of Science ®Google Scholar
• Hirsch FR, Franklin WA, Gazdar AF, Bunn PA Jr. (2001). Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 7:5–22
   PubMed Web of Science ®Google Scholar
• Huang Y, Yang YB, Zhang XH, et al. (2013). MicroRNA-21 gene and cancer. Med Oncol 30:376 . doi: 10.1007/s12032-012-0376-8 (9 pages)
   PubMed Web of Science ®Google Scholar
• Jazbutyte V, Thum T. (2010). MicroRNA-21: from cancer to cardiovascular disease. Curr Drug Targets 11:926–35
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, et al. (2008). Cancer statistics, 2008. CA Cancer J Clin 58:71–96
   PubMed Web of Science ®Google Scholar
• Jung HM, Patel RS, Cohen DM, et al. (2012). Subclassification of oral cancers using a miRNA-based combinatorial approach. Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31--Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 191. doi: 1538--7445. AM2012-191
   Google Scholar
• Kumarswamy R, Volkmann I, Thum T. (2011). Regulation and function of miRNA-21 in health and disease. RNA Biol 8:706–13
   PubMed Web of Science ®Google Scholar
• Lages E, Ipas H, Guttin A, et al. (2012). MicroRNAs: molecular features and role in cancer. Front Biosci 17:2508–40
   PubMed Web of Science ®Google Scholar
• Malerba M, Montuschi P. (2012). Non-invasive biomarkers of lung inflammation in smoking subjects. Curr Med Chem 19:187–96
   PubMed Web of Science ®Google Scholar
• Markou A, Sourvinou I, Vorkas PA, et al. (2013). Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Lung 81:388–96
   Web of Science ®Google Scholar
• Navon R, Wang H, Steinfeld I, et al. (2009). Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS One 4:e8003
   Web of Science ®Google Scholar
• Oh HK, Tan AL, Das K, et al. (2011). Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin Cancer Res 17:2657–67
   PubMed Web of Science ®Google Scholar
• Osman A. (2012). MicroRNAs in health and disease – basic science and clinical applications. Clin Lab 58:393–402
   PubMed Web of Science ®Google Scholar
• Pezzolesi MG, Platzer P, Eng C. (2008). Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome. Am J Hum Genet 82:1141–9
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
   PubMed Web of Science ®Google Scholar
• Pinkerton M, Chinchilli V, Banta E, et al. (2013). Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy adults. J Allergy Clin Immunol 132:217--19
   Google Scholar
• Rothschild SI. (2013). Epigenetic therapy in lung cancer -- role of microRNAs. Front Oncol 3:158 . doi: 10.3389/fonc.2013.00158 (8 pages)
   PubMedGoogle Scholar
• Seike M, Goto A, Okano T, et al. (2009). MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Nat Acad Sci USA 106:12085–90
   PubMed Web of Science ®Google Scholar
• Shen J, Todd NW, Zhang H, et al. (2011). Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest 91:579–87
   PubMed Web of Science ®Google Scholar
• Sinha A, Yadav AK, Chakraborty S, et al. (2013). Exosome-enclosed microRNAs in exhaled breath hold potential for biomarker discovery in patients with pulmonary diseases. J Allergy Clin Immunol 132:219--22
   Google Scholar
• Sozzi G, Pastorino U, Croce CM. (2011). MicroRNAs and lung cancer: from markers to targets. Cell Cycle 10:2045–6
   PubMed Web of Science ®Google Scholar
• Subramaniam S, Thakur RK, Yadav VK, et al. (2013). Lung cancer biomarkers: state of the art. J Carcinog 12:3 . doi: 10.4103/1477-3163.107958 (6 pages)
   PubMedGoogle Scholar
• Tang D, Shen Y, Wang M, et al. (2013). Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer. Eur J Cancer Prev 22:540--8
   Google Scholar
• Treiber T, Treiber N, Meister G. (2012). Regulation of microRNA biogenesis and function. Thromb Haemost 107:605–10
   PubMed Web of Science ®Google Scholar
• Vosa U, Vooder T, Kolde R, et al. (2013). Meta-analysis of microRNA expression in lung cancer. Int J Cancer 132:2884–93
   PubMed Web of Science ®Google Scholar
• Zhu S, Si ML, Wu H, Mo YY. (2007). MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282:14328–36
   PubMed Web of Science ®Google Scholar